Ann: PainChek completes A$5m capital raise, page-17

Expecting a re-rate due to the fact they now have sufficient funds to reach the most key milestones in the companies history. The recent raise sellers that wanted out as they are more focused on their fee's for putting the deal together, or a quick profit are mostly out judging by the multiple on screen sell amounts of around 1.2m shares (aka $30k new shares in the raise).

The nourish agreement which will speed up implementation (their major weakness) and factoring in FDA approval where only a fraction of the overall market need to take up the app for Painchek to turn a profit. Launch of infants app too. As well as Director participation in the recent raises after not buying on market for the whole pandemic period as they assessed if the business would survive. Lastly, the volume of buying this week, myself included

I expect the stock to re-rate or move consistently higher from here unless the US markets craps the bed.

p.s. how much are you down tiger? And why are you still a "Held, Hold" given your bearish sentiment. Happy Easter!